Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Tables)

v3.20.2
Organization and Nature of Operations (Tables)
9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of company's subsidiaries consolidated financial statements
Name of Subsidiary   Place and date of Incorporation   Percentage of Ownership   Principal Activities
Avalon Healthcare System, Inc. (“AHS”)   Delaware May 18, 2015   100% held by AVCO   Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in United States of America (“USA”)
             
Avalon (BVI) Ltd. (“Avalon BVI”)   British Virgin Island January 23, 2017   100% held by AVCO   Dormant, is in process of being dissolved
             
Avalon RT 9 Properties LLC (“Avalon RT 9”)   New Jersey February 7, 2017   100% held by AVCO   Owns and operates an income-producing real property and holds and manages the corporate headquarters
             
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”)   PRC April 29, 2016   100% held by AHS   Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in China
             
Genexosome Technologies Inc. (“Genexosome”)   Nevada July 31, 2017   60% held by AVCO   Develops proprietary diagnostic and therapeutic products using exosomes
             
Beijing Jieteng (Genexosome) Biotech Co., Ltd. (“Beijing Genexosome”)   PRC August 7, 2015   100% held by Genexosome   Provides development services for hospitals and other customers and sells developed items to hospitals and other customers in China
             
Avactis Biosciences Inc. (“Avactis”)   Nevada July 18, 2018   100% held by AVCO   Integrate and optimize global scientific and clinical resources to further advance cellular therapies, including regenerative medicine with stem/progenitor cells as well as cellular immunotherapy including CAR-T, CAR-NK, TCR-T and others to treat certain cancers
             
International Exosome Association LLC (“Exosome”)   Delaware June 13, 2019   100% held by AVCO   Promotes standardization related to exosome industry